Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-97.29	54.03	-1995.05
Graham Fair Price	-21.51	120202.14	153146.72
PEG	-232.44	-0.45	-0.14
Price/Book	6.66	0.54	0.51
Price/Cash Flow	-194.49	-25.53	-8.67
Prices/Earnings	68.89	17.01	10.07
Price/Sales	-0.62	0.80	0.80
Price/FCF	-194.49	-25.53	-8.67
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	86.53	0.08	0.04
Operating Margin	145.83	0.04	-0.02
ROA	-41.46	< 0.005	< 0.005
ROE	0.01	< 0.005	-36.84
ROIC	< 0.005	< 0.005	110.06
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	0.09	0.13	-31.05
Dividends QOQ	-1.00	0.00	inf
EBIT QOQ	-1.50	3.61	140.93
EPS QOQ	-0.74	-0.38	49.20
FCF QOQ	0.50	0.64	29.22
Revenue QOQ	-0.05	0.06	12.26
Naive Interpretation	member

03 - Financial Growth · Best

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	25.87	19.71	-23.82
Days Sales Outstanding (DSO)	41.52	61.08	47.10
Inventory Turnover	3.48	4.57	31.27
Debt/Capitalization	0.50	0.52	3.86
Quick Ratio	1.05	1.10	4.59
Naive Interpretation	member

04 - Leverage & Liquidity · Balanced

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	287583.18	284027.98	-1.24
Cash	86849.59	93941.52	8.17
Capex	-20165.30	-10896.26	45.97
Free Cash Flow	-16839.44	-6023.71	64.23
Revenue	181413.52	192300.52	6.00
Naive Interpretation	member

05 - Per Share Metrics · Best

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	1.70	1.47	-13.33
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-1279.65	35.53	-97.22
Naive Interpretation	Member

06 - Financial Health · Weak

Rating